NTAGI's COVID Working Group To Review SII's Covovax Data For Use In 12 Year Olds And Above

(link to source)

India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9.

Related posts

Which Type Of Gold Should You Buy This Akshaya Tritiya?


Premier League 2021-22: Bruno Guimaraes’s Brace Helps Newcastle United Beat Leicester City


Paris Saint-Germain Star Kylian Mbappe Wins Ligue 1’s Best Player Award For Third Time


Leave a Comment